SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Trump Victory in the Republican Primary
DJT 12.64-1.9%12:50 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jlallen who wrote (542)4/6/2016 10:36:38 PM
From: Wharf Rat  Read Replies (1) of 1289
 
"Never heard anyone but you and other assorted scumbags claim I was dishonest."

That's pretty much everybody.

Here's some breaking stoner news....

The DEA Will Consider Reclassifying Marijuana This Year

dcist.com

Shortly after a group of protesters paraded an inflatable joint emblazoned with the words "Obama Deschedule Cannabis Now!" in front of the White House, the Drug Enforcement Administration said it is considering just that.

In a 25-page letter to lawmakers, the DEA said they plan to decide in the "first half of 2016" if marijuana's federal status should be changed.

Federal law currently classifies marijuana—along with heroin, MDMA, mescaline, and other drugs—as a Schedule 1 classified substance, defined as having a "high potential for abuse" and "no currently accepted medical use." According to the agency, "schedule I drugs are the most dangerous drugs of all the drug schedules with potentially severe psychological or physical dependence."

Nearly half of the states, plus the District of Columbia and Guam, have passed laws to allow for some form of medical marijuana use.

According to the memo, the DEA has received a scheduling recommendation from the Food and Drug Administration, but it did not say what it was. The agency also said it is working with the FDA and the National Institute On Drug Abuse on a review of cannabidiol, which is often used to treat epilepsy, for a possible rescheduling as well.

The letter was in response to questions that eight Democratic senators sent at the end of December, including inquiries about the state of medical marijuana research.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext